Cover Image
Market Research Report

Dental Biomaterials - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 344642
Published Content info 158 Pages
Delivery time: 1-2 business days
Price
Back to Top
Dental Biomaterials - Medical Devices Pipeline Assessment, 2018
Published: March 1, 2018 Content info: 158 Pages
Description

GlobalData's Medical Devices sector report, "Dental Biomaterials - Medical Devices Pipeline Assessment, 2018" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dental Biomaterials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dental Biomaterials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0521EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Dental Biomaterials Overview 9

3 Products under Development 10

  • 3.1 Dental Biomaterials - Pipeline Products by Stage of Development 10
  • 3.2 Dental Biomaterials - Pipeline Products by Segment 11
  • 3.3 Dental Biomaterials - Pipeline Products by Territory 12
  • 3.4 Dental Biomaterials - Pipeline Products by Regulatory Path 13
  • 3.5 Dental Biomaterials - Pipeline Products by Estimated Approval Date 14
  • 3.6 Dental Biomaterials - Ongoing Clinical Trials 15

4 Dental Biomaterials - Pipeline Products under Development by Companies 16

  • 4.1 Dental Biomaterials Companies - Pipeline Products by Stage of Development 16
  • 4.2 Dental Biomaterials - Pipeline Products by Stage of Development 18

5 Dental Biomaterials Companies and Product Overview 20

  • 5.1 3-D Matrix Ltd Company Overview 20
  • 5.2 Aleo BME Inc Company Overview 21
  • 5.3 Collagen Matrix Inc Company Overview 22
  • 5.4 credentis AG Company Overview 25
  • 5.5 curasan AG Company Overview 26
  • 5.6 Daewoong Pharmaceutical Co Ltd Company Overview 28
  • 5.7 Harvard University Company Overview 29
  • 5.8 Histocell SL Company Overview 30
  • 5.9 Indian Institute of Technology Bombay Company Overview 31
  • 5.10 Ironwood Material Science Inc Company Overview 32
  • 5.11 Maxigen Biotech Inc Company Overview 33
  • 5.12 Medisse BV (Inactive) Company Overview 35
  • 5.13 Medtronic plc Company Overview 36
  • 5.14 Meta Biomed Co Ltd Company Overview 38
  • 5.15 Mimetis Company Overview 40
  • 5.16 NDSU Research Foundation Company Overview 41
  • 5.17 Nobel Biocare Holding AG Company Overview 42
  • 5.18 Novatissue SAS Company Overview 43
  • 5.19 Oregon Health & Science University Company Overview 44
  • 5.20 Orthocell Ltd Company Overview 45
  • 5.21 Orthogen LLC Company Overview 48
  • 5.22 Orthosera GmbH Company Overview 49
  • 5.23 PolyPid Ltd Company Overview 50
  • 5.24 Polytechnic University of Catalonia Company Overview 53
  • 5.25 REGENECURE Ltd Company Overview 54
  • 5.26 Resorba GmbH Company Overview 55
  • 5.27 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 58
  • 5.28 Straumann Holding AG Company Overview 59
  • 5.29 SurgaColl Technologies Ltd Company Overview 61
  • 5.30 SweetBio, Inc. Company Overview 62
  • 5.31 Tigran Technologies AB Company Overview 63
  • 5.32 University At Buffallo Company Overview 64
  • 5.33 University of Maryland Company Overview 65
  • 5.34 University of Queensland Company Overview 66

6 Dental Biomaterials- Recent Developments 67

  • 6.1 Feb 08, 2018: Zimmer Biomet's Rapid Recovery Program Marks Two Decades of Success in Europe 67
  • 6.2 Feb 08, 2018: Ivoclar Vivadent: 4th International Expert Symposium in Rome 67
  • 6.3 Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017 68
  • 6.4 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 71
  • 6.5 Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results 72
  • 6.6 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 73
  • 6.7 Jan 17, 2018: Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona 74
  • 6.8 Jan 17, 2018: Dentsply Sirona Announces the Addition of New Board Members 75
  • 6.9 Jan 16, 2018: CollPlant Appoints David Tsur as Chairman of the Board 75
  • 6.10 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 76
  • 6.11 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 77
  • 6.12 Dec 19, 2017: Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer 78
  • 6.13 Dec 18, 2017: Whip Mix Introduces a new 3D Print Resin for Dental Models 78
  • 6.14 Dec 14, 2017: Karolinska Development's Portfolio Company Promimic Receives FDA Approval For HAnano Surface For Use On Dental Implants 79
  • 6.15 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 79
  • 6.16 Dec 01, 2017: Ivoclar Vivadent expands its Corporate Management 80
  • 6.17 Nov 28, 2017: CollPlant Receives Substantial, Repeat Order for Its Biological Ink 80
  • 6.18 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 80
  • 6.19 Nov 08, 2017: Orthocell Receives CE Mark for CelGro 83
  • 6.20 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 84
  • 6.21 Nov 03, 2017: Dentsply Sirona Reports Third Quarter 2017 Results 85
  • 6.22 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 86
  • 6.23 Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 87
  • 6.24 Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results 88
  • 6.25 Oct 30, 2017: Exactech Q3 Revenue $61.4 Million 89
  • 6.26 Oct 30, 2017: Plastic Surgery Foundation and MTF Biologics Partnership Funds Advances in Tissue Transplantation 89
  • 6.27 Oct 26, 2017: Stryker reports third quarter 2017 results 90
  • 6.28 Oct 23, 2017: Philips' Third Quarter Results 2017 92
  • 6.29 Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips' Board of Management 94
  • 6.30 Oct 16, 2017: Orthocell granted CelGro patent protection in Canada 94
  • 6.31 Oct 16, 2017: Dentsply Sirona Announces Additions to Executive Leadership Team 95
  • 6.32 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 95
  • 6.33 Oct 06, 2017: PolarityTE Names International Leader in Plastic and Reconstructive Surgery Dr. Maurice Nahabedian as Chief Surgical Officer 96
  • 6.34 Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico 98
  • 6.35 Oct 03, 2017: World's Largest Tissue Bank Rebrands to MTF Biologics 98
  • 6.36 Oct 02, 2017: Dentsply Sirona Announces Leadership Changes 99
  • 6.37 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 100
  • 6.38 Sep 21, 2017: Bruce Stroever to Retire from Musculoskeletal Transplant Foundation 101
  • 6.39 Sep 19, 2017: Clinical trial proves superiority of Guided Enamel Regeneration with CURODONT REPAIR 101
  • 6.40 Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer 102
  • 6.41 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 103
  • 6.42 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 104
  • 6.43 Sep 06, 2017: Practice-based case series proves beneficial effect of CURODONT REPAIR in treatment of proximal caries lesions 105
  • 6.44 Aug 24, 2017: Philips appoints Egbert van Acht as Chief Business Leader of the Personal Health businesses, and proposes to appoint Marnix van Ginneken as member of the Board of Management 105
  • 6.45 Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee 106
  • 6.46 Aug 22, 2017: PolarityTE Recruits Jennifer Burdman, Partner at King & Spalding, to Serve as Chief Intellectual Property Officer 107
  • 6.47 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 108
  • 6.48 Aug 17, 2017: Admira Fusion Flow: "excellent" rating in eight out of eight categories 110
  • 6.49 Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement 111
  • 6.50 Aug 09, 2017: Dentsply Sirona Reports Second Quarter 2017 Results 115
  • 6.51 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 117
  • 6.52 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 117
  • 6.53 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 118
  • 6.54 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 118
  • 6.55 Jul 27, 2017: Stryker reports second quarter 2017 results 119
  • 6.56 Jul 27, 2017: Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue 120
  • 6.57 Jul 24, 2017: Philips' Second Quarter Results 2017 121
  • 6.58 Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 124
  • 6.59 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 124
  • 6.60 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 125
  • 6.61 Jun 30, 2017: PolarityTE Expands Clinical Board of Advisors with Focus on World-Renowned Burn and Wound Care Specialists 125
  • 6.62 Jun 27, 2017: PolarityTE Appoints Distinguished Major General Jay Hood of the U.S. Army as Director of Newly Created Military and Mass Casualty Advisory Board 128
  • 6.63 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 129
  • 6.64 Jun 13, 2017: MTF Announces Matthew Kuehnert, MD as New Medical Director 129
  • 6.65 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 130
  • 6.66 May 31, 2017: CollPlant Provides Operational Update for Q1 2017 131
  • 6.67 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 132
  • 6.68 Apr 28, 2017: Advanced Medical Solutions Group Reports 2016 Financial Results 135
  • 6.69 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 135
  • 6.70 Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 136
  • 6.71 Apr 25, 2017: Stryker reports first quarter 2017 results 139
  • 6.72 Apr 25, 2017: Exactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth 140
  • 6.73 Apr 24, 2017: Philips' First Quarter Results 2017 141
  • 6.74 Apr 24, 2017: Geistlich Pharma posts excellent 2016 results 143
  • 6.75 Apr 19, 2017: Philips couples sustainability performance to interest rate of its new EUR 1 billion Revolving Credit Facility 144
  • 6.76 Apr 13, 2017: Invibio: Around 9 million implanted devices worldwide now using PEEK-OPTIMA polymer -"International PEEK meeting" upcoming 144
  • 6.77 Mar 30, 2017: CollPlant Provides Commercial and Operational Update 145
  • 6.78 Mar 27, 2017: VOCO at IDS 2017: successful entry into the digital sector 146
  • 6.79 Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 147
  • 6.80 Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 151
  • 6.81 Mar 20, 2017: Philips reclassified to STOXX Europe 600 Health Care sector index 151
  • 6.82 Mar 17, 2017: Philips appoints Henk de Jong as Chief of International Markets 152
  • 6.83 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016 152
  • 6.84 Mar 10, 2017: Whip Mix Introduces Milling Services for Dental Laboratories 153
  • 6.85 Mar 07, 2017: Philips leads the world in filing patents at the European Patent Office for second consecutive year 153
  • 6.86 Mar 02, 2017: MTF Announces New Recovery Partner Relationship - LifeLink 154
  • 6.87 Mar 02, 2017: MTF Announces New Recovery Partner Relationship - New England Donor Services 154

7 Appendix 155

  • 7.1 Methodology 155
  • 7.2 About GlobalData 158
  • 7.3 Contact Us 158
  • 7.4 Disclaimer 158

List of Tables

1.1 List of Tables

  • Table 1: Dental Biomaterials - Pipeline Products by Stage of Development 10
  • Table 2: Dental Biomaterials - Pipeline Products by Segment 11
  • Table 3: Dental Biomaterials - Pipeline Products by Territory 12
  • Table 4: Dental Biomaterials - Pipeline Products by Regulatory Path 13
  • Table 5: Dental Biomaterials - Pipeline Products by Estimated Approval Date 14
  • Table 6: Dental Biomaterials - Ongoing Clinical Trials 15
  • Table 7: Dental Biomaterials Companies - Pipeline Products by Stage of Development 16
  • Table 8: Dental Biomaterials - Pipeline Products by Stage of Development 18
  • Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 10: PuraMatrix Bone Void Filler - Product Status 20
  • Table 11: PuraMatrix Bone Void Filler - Product Description 20
  • Table 12: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 13: Dental Adhesive - Product Status 21
  • Table 14: Dental Adhesive - Product Description 21
  • Table 15: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 16: MatrixMem - Product Status 22
  • Table 17: MatrixMem - Product Description 22
  • Table 18: Socket Repair Kit - Product Status 23
  • Table 19: Socket Repair Kit - Product Description 23
  • Table 20: SynOss Granules - Product Status 23
  • Table 21: SynOss Granules - Product Description 24
  • Table 22: SynOss Putty - Product Status 24
  • Table 23: SynOss Putty - Product Description 24
  • Table 24: credentis AG Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 25: CUROLOX Scaffold - Product Status 25
  • Table 26: CUROLOX Scaffold - Product Description 25
  • Table 27: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 28: Cerasorb Foam Dental - Product Status 26
  • Table 29: Cerasorb Foam Dental - Product Description 26
  • Table 30: Cerasorb Paste Dental - Product Status 27
  • Table 31: Cerasorb Paste Dental - Product Description 27
  • Table 32: Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 33: NOVOSIS - DENT - Product Status 28
  • Table 34: NOVOSIS - DENT - Product Description 28
  • Table 35: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 36: Artificial Teeth - Product Status 29
  • Table 37: Artificial Teeth - Product Description 29
  • Table 38: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 39: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status 30
  • Table 40: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description 30
  • Table 41: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 42: Electrospun - Product Status 31
  • Table 43: Electrospun - Product Description 31
  • Table 44: Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 45: GEMOSIL - Dental Implant - Product Status 32
  • Table 46: GEMOSIL - Dental Implant - Product Description 32
  • Table 47: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 48: MaxiBone - Product Status 33
  • Table 49: MaxiBone - Product Description 33
  • Table 50: MaxiGuide - Product Status 34
  • Table 51: MaxiGuide - Product Description 34
  • Table 52: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 53: Dental Membrane - Product Status 35
  • Table 54: Dental Membrane - Product Description 35
  • Table 55: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 56: MD05-P Bone Graft Substitute Material - Product Status 36
  • Table 57: MD05-P Bone Graft Substitute Material - Product Description 36
  • Table 58: MD08 Injectable Paste - Product Status 37
  • Table 59: MD08 Injectable Paste - Product Description 37
  • Table 60: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 61: Biocompatible Sealer - Product Status 38
  • Table 62: Biocompatible Sealer - Product Description 38
  • Table 63: Endodontic Sealer - Product Status 39
  • Table 64: Endodontic Sealer - Product Description 39
  • Table 65: Root Canal Sealer - Product Status 39
  • Table 66: Root Canal Sealer - Product Description 39
  • Table 67: Mimetis Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 68: Foamimetik - Product Status 40
  • Table 69: Foamimetik - Product Description 40
  • Table 70: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 71: Synthetic Mandible - Product Status 41
  • Table 72: Synthetic Mandible - Product Description 41
  • Table 73: Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 74: Bone Inductive Implant - Product Status 42
  • Table 75: Bone Inductive Implant - Product Description 42
  • Table 76: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 77: OrthoNovaOss - Product Status 43
  • Table 78: OrthoNovaOss - Product Description 43
  • Table 79: Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 80: Durable Dental Composite - Product Status 44
  • Table 81: Durable Dental Composite - Product Description 44
  • Table 82: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 83: CelGro - Dental - Product Status 45
  • Table 84: CelGro - Dental - Product Description 45
  • Table 85: Orthocell Ltd - Ongoing Clinical Trials Overview 46
  • Table 86: CelGro - Dental - Single-center, Open-label, Pilot Study of Celgro Collagen Membrane for Guided Bone Regeneration Around Exposed Dental Implants in Patients Undergoing Dental Implant Surgery 47
  • Table 87: Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 88: DentoGen-CR - Product Status 48
  • Table 89: DentoGen-CR - Product Description 48
  • Table 90: Orthosera GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 91: Antibiotic Bone Graft - Product Status 49
  • Table 92: Antibiotic Bone Graft - Product Description 49
  • Table 93: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 94: BonyPid-500 - Product Status 50
  • Table 95: BonyPid-500 - Product Description 50
  • Table 96: PolyPid Ltd - Ongoing Clinical Trials Overview 51
  • Table 97: BonyPid-500 - PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute 52
  • Table 98: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 99: Inorganic Dental Cement - Product Status 53
  • Table 100: Inorganic Dental Cement - Product Description 53
  • Table 101: REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 102: Regenecure AMCA GBR Dental Membrane Implant - Product Status 54
  • Table 103: Regenecure AMCA GBR Dental Membrane Implant - Product Description 54
  • Table 104: Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 105: PARASORB Fleece - Product Status 55
  • Table 106: PARASORB Fleece - Product Description 55
  • Table 107: PARASORB Fleece Genta HD - Product Status 56
  • Table 108: PARASORB Fleece Genta HD - Product Description 56
  • Table 109: PARASORB Fleece HD - Product Status 56
  • Table 110: PARASORB Fleece HD - Product Description 57
  • Table 111: PARASORB RESODONT - Product Status 57
  • Table 112: PARASORB RESODONT - Product Description 57
  • Table 113: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 114: BioCaS - Product Status 58
  • Table 115: BioCaS - Product Description 58
  • Table 116: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 117: Ceramic Injection Molding Dental Material - Product Status 59
  • Table 118: Ceramic Injection Molding Dental Material - Product Description 59
  • Table 119: Enhanced Bone Graft - Product Status 60
  • Table 120: Enhanced Bone Graft - Product Description 60
  • Table 121: Soft Tissue Control Implant - Product Status 60
  • Table 122: Soft Tissue Control Implant - Product Description 60
  • Table 123: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 124: DentaColl - Product Status 61
  • Table 125: DentaColl - Product Description 61
  • Table 126: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 127: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status 62
  • Table 128: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description 62
  • Table 129: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 130: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status 63
  • Table 131: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description 63
  • Table 132: University At Buffallo Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 133: Root Canal Scaffold - Product Status 64
  • Table 134: Root Canal Scaffold - Product Description 64
  • Table 135: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 136: Injectable Scaffold - Product Status 65
  • Table 137: Injectable Scaffold - Product Description 65
  • Table 138: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 139: Dental Material - Product Status 66
  • Table 140: Dental Material - Product Description 66
  • Table 141: Glossary 157
Back to Top